A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol.
Saved in:
| Title: | A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol. |
|---|---|
| Authors: | Georgiou-Karistianis N; School of Psychological Sciences, The Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia., Corben LA; Bruce Lefroy Centre for Genetic Health Research, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia., Reetz K; Department of Neurology, RWTH Aachen University, Aachen, Germany.; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany., Adanyeguh IM; Center for Magnetic Resonance Research and Department of Radiology, University of Minnesota, Minneapolis, Minnesota, United States of America., Corti M; Powell Gene Therapy Centre, University of Florida, Gainesville, Florida, United States of America., Deelchand DK; Center for Magnetic Resonance Research and Department of Radiology, University of Minnesota, Minneapolis, Minnesota, United States of America., Delatycki MB; School of Psychological Sciences, The Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.; Bruce Lefroy Centre for Genetic Health Research, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia., Dogan I; Department of Neurology, RWTH Aachen University, Aachen, Germany.; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany., Evans R; Takeda Pharmaceutical Company Ltd, Cambridge, Massachusetts, United States of America., Farmer J; Friedreich's Ataxia Research Alliance (FARA), Downingtown, Pennsylvania, United States of America., França MC; Department of Neurology, University of Campinas, Campinas, Sao Paulo, Brazil., Gaetz W; Department of Radiology, Lurie Family Foundations MEG Imaging Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America., Harding IH; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia., Harris KS; School of Psychological Sciences, The Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia., Hersch S; Neurology Business Group, Eisai Inc., Nutley, New Jersey, United States of America., Joules R; IXICO plc, London, England., Joers JJ; Center for Magnetic Resonance Research and Department of Radiology, University of Minnesota, Minneapolis, Minnesota, United States of America., Krishnan ML; Translational Medicine, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America., Lax M; IXICO plc, London, England., Lock EF; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, United States of America., Lynch D; Department of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America., Mareci T; Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL, United States of America., Muthuhetti Gamage S; School of Psychological Sciences, The Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia., Pandolfo M; Department of Neurology and Neurosurgery, McGill University, Montreal, Canada., Papoutsi M; IXICO plc, London, England., Rezende TJR; Department of Neurology, University of Campinas, Campinas, Sao Paulo, Brazil., Roberts TPL; Department of Radiology, Lurie Family Foundations MEG Imaging Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America., Rosenberg JT; McKnight Brain Institute, Department of Neurology, University of Florida, Gainesville, Florida, United States of America., Romanzetti S; Department of Neurology, RWTH Aachen University, Aachen, Germany.; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany., Schulz JB; Department of Neurology, RWTH Aachen University, Aachen, Germany.; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany., Schilling T; PTC Therapeutics, Inc, South Plainfield, New Jersey, United States of America., Schwarz AJ; Takeda Pharmaceutical Company Ltd, Cambridge, Massachusetts, United States of America., Subramony S; McKnight Brain Institute, Department of Neurology, University of Florida, Gainesville, Florida, United States of America., Yao B; PTC Therapeutics, Inc, South Plainfield, New Jersey, United States of America., Zicha S; Takeda Pharmaceutical Company Ltd, Cambridge, Massachusetts, United States of America., Lenglet C; Center for Magnetic Resonance Research and Department of Radiology, University of Minnesota, Minneapolis, Minnesota, United States of America., Henry PG; Center for Magnetic Resonance Research and Department of Radiology, University of Minnesota, Minneapolis, Minnesota, United States of America. |
| Source: | PloS one [PLoS One] 2022 Nov 21; Vol. 17 (11), pp. e0269649. Date of Electronic Publication: 2022 Nov 21 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial Protocol |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
